Journals / Selçuk Tıp Dergisi / 2004 / Cilt: 20 - Sayı: 4

Comparison of TC-99M sestamibi with I-131 whole body scans in differentiated thyroid carcinoma patients

Differansiye tiroid kanserli hastalarda I-131 taramalar ve TC-99M sestamibi tüm vücut taramaların karşılaştırılması

Pages
128–134
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results showed that Tc-99m sestamibi whole body images are highly sensitive and specific in differentiated thyroid carcinoma patients without thyroid supression (T4-offj, compared to conventional 1-31 whole body scans (kappa=O. 68 p<0.001).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study evaluated the potential of Tc-99m sestamibi whole body scan as an alternative to whole body 1-131 scan for well differentiated thyroid cancer patients prior to 1-131 ablation and post ablation states.
📊
Key Findings & Data:We evaluated 115 patients with differentiated thyroid cancer who had total or near total thyroidectomy.
💡
Conclusion & Impact:The results showed that Tc-99m sestamibi whole body images are highly sensitive and specific in differentiated thyroid carcinoma patients without thyroid supression (T4-offj, compared to conventional 1-31 whole body scans (kappa=O. 68 p<0.001).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tiroid neoplazmları · Teknesyum Tc 99m sestamibi · Radyofarmasötikler

Abstract

This study evaluated the potential of Tc-99m sestamibi whole body scan as an alternative to whole body 1-131 scan for well differentiated thyroid cancer patients prior to 1-131 ablation and post ablation states. We evaluated 115 patients with differentiated thyroid cancer who had total or near total thyroidectomy. All patients had undergone Tc-99m sestamibi whole body scanning, high resolution neck ultrasonography prior to conventional I-131 whole body scanning, thyrog/obulin, and antithyroglobulin values measured. Also all patients had neck and chest CT without contrast agent. The results showed that Tc-99m sestamibi whole body images are highly sensitive and specific in differentiated thyroid carcinoma patients without thyroid supression (T4-offj, compared to conventional 1-31 whole body scans (kappa=O. 68 p<0.001). Neck USG with Tc-99m sestamibi is comparable with conventional iodine based whole body studies also compared to high dose post -ablation 6th dayl-131 whole body scans. Neck USG increases sensitivity and decreases specificity of Tc-99m sestamibi scans. Clinical investigations had to be made to evaluate the efficiency of Tc-99m sestamibi in patients receiving thyroid supression.

Özet

Bu çalışma ablasyon öncesi ve sonrasında iyi differansiye tiroid kanserli hastalarda alternatif tarama yöntemi olarak Tc-99m sestamibi'nin kullanılıp kullanılamayacağını değerlendirmiştir. Bu nedenle total veya totale yakın tiroidektomi uygulanan 115 differansiye tiroid kanseri hastası çalışmaya alındı. Tüm hastalara Tc-99m sestamibi tüm vücut tarama, yüksek rezolusyonlu boyun USG, serum tiroglobulin ve antitiroglobulin olçümleri ve kontrastsiz boyun ve toraks tomografileri yapıldı. Sonuçlar göstermiştir ki Tc-99m Sestamibi tüm vücut taramalar, I-131 taramalarla karşılaştırıldığında tiroid supresyonu almayan (T4-offj hastalarda yüksek derecede sensitif ve spesifiktir (kappa =0.68 p<0.00 I). Boyun USG He birlikte Tc-99m sestamibi yapılması, yüksek doz 1-131 ablasyonu sonrası 6. gün taramalarla karşılastırılabilir etkinliğe sahiptir. Boyun USG, Tc-99m Sestamibi'nin sensitivitesini arttırırken spesifisitesini azaltır. Ancak Tc-99m Sestamibinin tiroid supresyonu alan hastalarda etkinliğinin değerlendirilmesi için klinik çalışmalara ihtiyaç vardır.

🔖

Cite This Article

AYAN, A., AKİN, A., KOCA, G., KIR, K. M. (2004). Comparison of TC-99M sestamibi with I-131 whole body scans in differentiated thyroid carcinoma patients. Selçuk Tıp Dergisi, Cilt: 20 - Sayı: 4, 128–134. https://ajindex.com/articles/319222

References (1)

  1. Maxon HR, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990; 19:685-718 2.Meier CA Braverman LE, Ebner SA, Veronikis I, Daniel GH, Ross DS, et al. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma ^hase l/ll study), J Clin Endocrinol Metah 1994; 78:188-96 3.Miyamoto S, Kasagai K,Misaki T, Alam MS, Konishi J. Evaluation of tecnnetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma. J Nucl Med 1997;38:352-6 4.Oyen WJ, Verhagen C, Saris E, van den Broek Wj, Pieters GF, Corsten FH. Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal. J Nucl Med 2000; 41:643-6 5.Pacini F, Lippi F, Formica N, Elisei R, Anelli S, Ceccarelli C, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer with detectable serum thyroglobulin levels. J Nucl Med 1987' 28'1888-91 6.Mc Dougall IR:72 MBq radioiodine 131-1 does not prevent uptake of therapeutic doses of 131 -I (i.e. it does not cause stunning) in differentiated thyroid cancer Nucl Med Commun 1997; 18:505-12 7.Muratet JP, Daver A, Minier JF, Larra F, et.al. Influence of scanning doses of iodine- - 131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma,J Nucl Med 1998; 39: 1546-50 8.Muratet JP, Giraud P, Daver A, Minier JF, Gamelin E, Larra F, et al. Predicting the efficacy of first 1-131 treatment in differentiated thyroid carcinoma, J Nucl Med 1997; 38:1362-8 9.Park HM, Park Yh, Zhou XH. Detection of thyroid remnant /metastasis without stunning. An ongoing dilemma. Thyroid 1997; 7:277-80 10.Cholewinsky SP, Yoo KS, Klieger PS, O'Mara RE. Absence of thyroid scanning after diagnostic whole-body scanning with 185 MBq 1-131. J.Nucl Med 2000; 41:1198-202 11.Maxon HR; Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well-differeifitiated thyroid cancer. Endocrinol Metab Clin North Am 1990; 19:685-718 12.Kasagi K, Miyamoto S, Endo K, Saoayama S, Takeuchi R, Hidaka A, et al. Increased uptake of iodine-131 in metastases of differentiated thyroid carcinoma associated with less severe hypothyroidism following total thyroidectomy. Cancer 1993; 72:1983-90 13.Khammash N,Halkar R.Abdel-Dayem HM. The use of Tc-99m pertechnetate in postoperative thyroid carcinoma:A comparative study with iodine-13. Clin Nucl Med 1988; 13:17